Regeneron (REGN)
@REGN.asset
$605.61
At close:
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
Figures
- Sector Healthcare
- Industry Biotechnology
- Index Nasdaq-100, S&P 500
- Market Cap $65.38 B
- Last Earnings Report Apr 29, 2025
- Price Reaction to Earnings Report -7.56%
- Enterprise Value $49.74 B
- Dividend Yield 0.00%
- P/E ratio 14.49
- Price/Sales ratio 4.63
- EV/Sales ratio 3.53
- Price/Book Value 2.22
- Revenue $14.09 B
- EBIT $5.14 B
- Net Income $4.50 B
- Gross Profit $12.08 B
- Free Cash Flow $3.12 B
- EBIT Margin 36.48%
- Gross Margin 85.79%
- FCF Margin 22.16%
- Return on Equity 15.31%
- Equity Ratio 78.27%
- Debt/Equity Ratio 0.28
- 6-month Performance -28.12%
- 12-month Performance -35.33%
- Trend reversal neutral
What the community is saying
| Nobody said anything, yet! Speak your mind and be the first to create a new topic. |